Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Persistent polyomavirus-associated nephropathy in a patient with GvHD and treatment with the JAK1/2 inhibitor ruxolitinib.

× No keyword cloud information.

11 in total

Review 1. Immunological Consequences of JAK Inhibition: Friend or Foe?

Authors: Donal P McLornan; Alesia A Khan; Claire N Harrison
Journal: Curr Hematol Malig Rep Date: 2015-12 Impact factor: 3.952

2. Ruxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH trials.

Authors: Madan Jagasia; Robert Zeiser; Michael Arbushites; Patricia Delaite; Brian Gadbaw; Nikolas von Bubnoff
Journal: Immunotherapy Date: 2018-01-10 Impact factor: 4.196

3. Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients.

Authors: Pooja Khandelwal; Ashley Teusink-Cross; Stella M Davies; Adam S Nelson; Christopher E Dandoy; Javier El-Bietar; Rebecca A Marsh; Ashish R Kumar; Michael S Grimley; Sonata Jodele; Kasiani C Myers
Journal: Biol Blood Marrow Transplant Date: 2017-03-23 Impact factor: 5.742

4. Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center.

Authors: Aliana Meneses Ferreira; Carolina Atallah Pontes da Silva; André Domingues Pereira; Roberta Shcolnik Szor; Ana Rita Brito Medeiros da Fonseca; Mariana Gomes Serpa; Erick Menezes Xavier; Michelly Kerly Sampaio de Melo; Yana Novis; Luciana Tucunduva; Vanderson Rocha; Celso Arrais-Rodrigues
Journal: Bone Marrow Transplant Date: 2018-01-12 Impact factor: 5.483

5. Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients.

Authors: S Busque; J Leventhal; D C Brennan; S Steinberg; G Klintmalm; T Shah; S Mulgaonkar; J S Bromberg; F Vincenti; S Hariharan; D Slakey; V R Peddi; R A Fisher; N Lawendy; C Wang; G Chan
Journal: Am J Transplant Date: 2009-08 Impact factor: 8.086

Persistent polyomavirus-associated nephropathy in a patient with GvHD and treatment with the JAK1/2 inhibitor ruxolitinib.

Review 1. Immunological Consequences of JAK Inhibition: Friend or Foe?

2. Ruxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH trials.

3. Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients.

4. Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center.

5. Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients.

6. Inhibitory effect of gamma interferon on BK virus gene expression and replication.

Review 7. Targeting JAK3 in kidney transplantation: current status and future options.

Review 8. BK virus nephropathy after allogeneic stem cell transplantation: a case report and literature review.

9. BK polyomavirus in solid organ transplantation.

10. BK nephropathy in pediatric hematopoietic stem cell transplant recipients.